NIH-funded research R21 grant

How opioids affect tau protein in the brain

Official title: Functional consequences of the interactions between tau protein and opioids

Funded at University of Minnesota · NIH-10874247 · Data updated 2026-11-12

This study is looking at how using opioids might affect certain proteins in the brain that are linked to memory and thinking problems, and it hopes to find new ways to help people who struggle with opioid use.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 15, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$239,963
NIH project number1R21DA058746-01A1
Project IDNIH-10874247 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of opioid use or those at risk for opioid use disorder.

Less likely to help

Patients who have never used opioids or do not have any neurological conditions may not benefit from this research.

What this research studies

This research investigates the relationship between opioid use and tau protein levels in the brain, particularly focusing on how opioids may influence neurobehavioral outcomes. The study aims to understand whether the increase in phosphorylated tau, which is associated with neurodegenerative diseases like Alzheimer's, has significant implications for brain health or is merely a byproduct of opioid use. By exploring these interactions, the research seeks to uncover potential new therapeutic approaches for opioid use disorder and its effects on the brain.

Why it matters

Potential benefit: If successful, this research could lead to novel treatments for opioid use disorder and improve understanding of its impact on brain health.

How similar studies have gone: While the relationship between opioids and tau protein is being explored, this specific focus on non-neurodegenerative roles of tau in opioid use is relatively novel.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Atwood, Brady — University of Minnesota
  • Study coordinator: Atwood, Brady

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.